Supplementary Figure 3. SMAD3 inhibition sensitizes oxaliplatin treated EAC cells to apoptosis.
No takes yet. Share an insight, caveat, or question.
Ballout et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: